Business Wire- ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes.
Recent Posts
MyUPMC experiences major jump in video visits as patients move to online care
More patients than ever are heading for UPMC’s digital front door as the COVID-19 pandemic …
Read More →
Spurred by crisis, telemedicine is revolutionizing health care as we know it
Telemedicine, the remote delivery of health care using video and audio communication tools, is demonstrating …
Read More →